Loading...
InterCure Ltd.
INCR•NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$1.53
$-0.03(-1.83%)
InterCure Ltd. (INCR) Stock Overview
Explore InterCure Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
-32.82%
↓ 32.82%
Profit Growth
$-0.67
↓ 9.42%
EPS Growth
$-0.67
↓ 8.82%
Operating Margin
-8.11%
↓ 61.69%
ROE
-7.24%
↓ 9.42%
Dividend Yield
0.00%
Analyst Recommendations data is not available for INCRAnalyst Recommendations details for INCR are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.
CEO
Mr. Alexander Rabinovich
Employees
320
Headquarters
85 Medinat ha-Yehudim Street, Herzliya
Founded
2019